| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |